Mutares Navigates Dividend Dip as Analyst Sees 77% Upside and Twin Exits Near Completion
Published on 07/06/2026 at 15:07 | Redaktion boerse-global.de
Mutares shares opened the new trading week with a textbook dividend-related discount, but beneath the surface the Munich-based private equity group is laying strategic groundwork that one analyst believes could drive the stock nearly 80 percent higher.
The stock shed 2.62 percent to trade at €27.85 on Monday, reflecting the €2.00 per share interim dividend approved at Friday’s annual general meeting. Adjusted for the payout, the shares actually opened above the theoretical ex-dividend level of €26.60, suggesting underlying demand remains intact. The dividend is scheduled for payment on July 8, 2026.
Sphene Capital Sees Wide Valuation Gap
In a note published the same day, Sphene Capital analyst Peter Thilo Hasler reaffirmed a “Buy” rating and a target price of €49.40 — implying a 77 percent premium over the current market price. Hasler cited the AGM outcomes and the company’s strategic progress, particularly the planned U.S. expansion that he expects to unlock significant liquidity in the second half of the year. The firm’s “well-filled exit pipeline” should also help narrow the valuation gap to fair value, he argued.
AGM Sets Three Strategic Pillars
Beyond the dividend, the July 3 shareholder meeting in Munich approved three key decisions. Mutares will establish a new “Chemicals & Materials” segment as a future growth platform, further diversifying the portfolio. Shareholders also appointed PricewaterhouseCoopers as the new auditor for fiscal 2026, a move the company attributed to increasing transaction complexity. And management confirmed a strong focus on the U.S. market, where it has identified a substantial transaction pipeline.
Should investors sell immediately? Or is it worth buying Mutares?
The boards of management and supervisory board were both discharged with clear majorities for 2025. CIO Johannes Laumann and CFO Mark Friedrich reiterated the 2026 guidance: a holding net profit between €165 million and €200 million.
Exit Calculus: NEM Energy and Efacec in the Spotlight
The third quarter promises concrete portfolio sales. The most immediate milestone is the sale of the NEM Energy Group to Hyundai Heavy Industries, with closing expected in the coming weeks. Separately, the Portuguese subsidiary Efacec is attracting attention following news that Mutares is reviewing strategic options with JPMorgan as advisor. A full sale or an initial public offering in Lisbon are both under consideration, though the board has yet to make a formal decision.
Technical Picture: Below the 200-Day Line but Building a Base
Chart-wise, the stock is holding 1.30 percent above its 50-day moving average of €27.49, a modestly constructive signal. However, it continues to trade below its 200-day average of €28.91, a level technicians view as a critical hurdle for a sustainable uptrend. The relative strength index stands at a neutral 45.9, leaving room for directional moves in either direction.
Mutares at a turning point? This analysis reveals what investors need to know now.
Year-to-date the shares remain roughly four percent in the red, but the 52-week low of €23.30 provides a solid floor. For now, the dividend discount has temporarily depressed the stock’s optical level, but market participants will be watching for operational catalysts — particularly the NEM Energy closing and any formal Efacec announcement — to drive the shares toward the analyst’s ambitious target.
Ad
Mutares Stock: New Analysis - 6 July
Fresh Mutares information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
